The Irish Times

Washington turmoil is proving a bitter pill for Pfizer

Pharma giant facing into expiry of key patents and investors are becoming itchy

Mon Jun 12 2017 - 17:20

Fear of overpaying cools mergers and acquisitions activity to $753 billion in quarter

Fri Sept 30 2016 - 13:26

Company’s shares down 1.3% in premarket trading after it says it will not separate

Mon Sept 26 2016 - 13:06

Irish shares fare better than wider European market, with Kingspan’s 7% rise leading way

Tue Aug 23 2016 - 01:00

Sanofi, Merck, Celgene and Gilead Sciences also believed to have been interested in firm

Mon Aug 22 2016 - 12:14

French pharma firm courts cancer group Medivation as key drugs face generics

Fri Jul 29 2016 - 13:22

French drugmaker’s advances have been rebuffed

Thu Apr 28 2016 - 12:43